These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17166979)

  • 1. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?
    Chin KM; Channick RN; Rubin LJ
    Chest; 2006 Dec; 130(6):1657-63. PubMed ID: 17166979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New risks for pulmonary hypertension: need for a large epidemiologic study.
    Willers ED; Newman JH
    Chest; 2006 Dec; 130(6):1633-5. PubMed ID: 17166972
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary Arterial Hypertension and Dilated Cardiomyopathy.
    Zhao SX; Kwong C; Swaminathan A; Gohil A; Crawford MH
    JACC Heart Fail; 2018 Mar; 6(3):209-218. PubMed ID: 29496022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.
    Zamanian RT; Hedlin H; Greuenwald P; Wilson DM; Segal JI; Jorden M; Kudelko K; Liu J; Hsi A; Rupp A; Sweatt AJ; Tuder R; Berry GJ; Rabinovitch M; Doyle RL; de Jesus Perez V; Kawut SM
    Am J Respir Crit Care Med; 2018 Mar; 197(6):788-800. PubMed ID: 28934596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study.
    Lang IM; Simonneau G; Pepke-Zaba JW; Mayer E; Ambrož D; Blanco I; Torbicki A; Mellemkjaer S; Yaici A; Delcroix M
    Thromb Haemost; 2013 Jul; 110(1):83-91. PubMed ID: 23677493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine and idiopathic pulmonary arterial hypertension: role of the serotonin transporter.
    Rothman RB; Baumann MH
    Chest; 2007 Oct; 132(4):1412-3. PubMed ID: 17934137
    [No Abstract]   [Full Text] [Related]  

  • 8. Physical health, illicit drug use, and demographic characteristics in rural stimulant users.
    Garrity TF; Leukefeld CG; Carlson RG; Falck RS; Wang J; Booth BM
    J Rural Health; 2007; 23(2):99-107. PubMed ID: 17397365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic thromboembolic pulmonary hypertension: an underdiagnosed entity?
    Ali JM; Hardman G; Page A; Jenkins DP
    Hosp Pract (1995); 2012 Aug; 40(3):71-9. PubMed ID: 23086096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in a national cohort of patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.
    Roman A; Barbera JA; Castillo MJ; Muñoz R; Escribano P
    Arch Bronconeumol; 2013 May; 49(5):181-8. PubMed ID: 23452896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
    Rådegran G; Kjellström B; Ekmehag B; Larsen F; Rundqvist B; Blomquist SB; Gustafsson C; Hesselstrand R; Karlsson M; Kornhall B; Nisell M; Persson L; Ryftenius H; Selin M; Ullman B; Wall K; Wikström G; Willehadson M; Jansson K;
    Scand Cardiovasc J; 2016 Aug; 50(4):243-50. PubMed ID: 27146648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of chronic thromboembolic pulmonary hypertension in Korea: results from the Korean registry.
    Park SY; Lee SM; Shin JW; Choi BW; Kim H; Lee JS; Lee SD; Park SS; Moon HS; Park YB
    Korean J Intern Med; 2016 Mar; 31(2):305-12. PubMed ID: 26689916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.
    Guilpain P; Montani D; Damaj G; Achouh L; Lefrère F; Le Pavec J; Marfaing-Koka A; Dartevelle P; Simonneau G; Humbert M; Hermine O
    Respiration; 2008; 76(3):295-302. PubMed ID: 18160817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension.
    Yaoita N; Shirakawa R; Fukumoto Y; Sugimura K; Miyata S; Miura Y; Nochioka K; Miura M; Tatebe S; Aoki T; Yamamoto S; Satoh K; Kimura T; Shimokawa H; Horiuchi H
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2486-94. PubMed ID: 25169936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism.
    Guérin L; Couturaud F; Parent F; Revel MP; Gillaizeau F; Planquette B; Pontal D; Guégan M; Simonneau G; Meyer G; Sanchez O
    Thromb Haemost; 2014 Sep; 112(3):598-605. PubMed ID: 24898545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension.
    Charoenpong P; Hall NM; Keller CM; Ram AK; Murnane KS; Goeders NE; Dhillon NK; Walter RE
    Chest; 2024 Jun; 165(6):1518-1533. PubMed ID: 38211700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost to managed care of managing pulmonary hypertension.
    Said Q; Martin BC; Joish VN; Kreilick C; Mathai SC
    J Med Econ; 2012; 15(3):500-8. PubMed ID: 22313330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors.
    Korkmaz A; Ozlu T; Ozsu S; Kazaz Z; Bulbul Y
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):281-8. PubMed ID: 22275389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic thromboembolic pulmonary hypertension.
    Kim NH; Delcroix M; Jenkins DP; Channick R; Dartevelle P; Jansa P; Lang I; Madani MM; Ogino H; Pengo V; Mayer E
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D92-9. PubMed ID: 24355646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
    Kolaitis NA; Zamanian RT; de Jesus Perez VA; Badesch DB; Benza RL; Burger CD; Chakinala MM; Elwing JM; Feldman J; Lammi MR; Mathai SC; McConnell JW; Presberg KW; Robinson JC; Sager J; Shlobin OA; Simon MA; Kawut SM; Glidden DV; Singer JP; De Marco T;
    Ann Am Thorac Soc; 2021 Apr; 18(4):613-622. PubMed ID: 33064950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.